BioGenes is specialised in 2D Gel Analysis of HCPs

See our latest poster presentation!

A New Generation of Generic HCP ELISAs

The 360-HCP ELISA Approach

The enhanced generic 360-HCP approach produces host cell protein (HCP) assays that are demonstrably superior to traditional generic HCP assays minimizing well-known limitations including the possibility that anti-HCP antibodies might not comprehensively detect HCPs present in an end-user's sample. While traditional generic HCP assays provide just a single antibody that must work for all processes the enhanced generic 360-HCP ELISA provides four kits, each using a different anti-HCP antibody so you can try multiple antibodies to find the one that works best for your samples.

This unique approach increases the assay specificity and sensitivity and allows sponsors and biotech companies to postpone the development of a cost-intensive specific HCP assay until a more informed decision on the success of a biologic in development can be made.

How it works – using the example of CHO|360-HCP ELISA


Dr. Yvonne Haberkorn
Head of Product Dev. & Production
+49 (0)30 65762378